Articles for GlaxoSmithKline (LSE: GSK)

3 top FTSE 100 dividend stocks I’m buying right now

Rupert Hargreaves highlights his three favourite FTSE 100 (INDEXFTSE: UKX) dividend stocks. More »

Here’s why the GSK share price could climb while Spire Healthcare sinks by 20%+

GlaxoSmithKline plc (LON: GSK) appears to offer better investment potential than Spire Healthcare plc (LON: SPI). More »

Here’s why the GSK share price could be set to beat the FTSE 100

GlaxoSmithKline plc (LON: GSK) shares have been lagging the FTSE 100, but could 2018's comeback mark a new upward trend? More »

How did FTSE 100 dividend stock GlaxoSmithKline get to be so risky?

Harvey Jones hopes FTSE 100 (INDEXFTSE: UKX) income stalwart GlaxoSmithKline plc (LSE: GSK) can pull off its tricky balancing act. More »

Is GlaxoSmithKline a high-yield dividend star or a dangerous dog of the FTSE 100?

How sustainable is the GlaxoSmithKline plc (LON: GSK) dividend? More »

GlaxoSmithKline isn’t the only high yield pharma stock I’d buy today

GlaxoSmithKline plc (LON: GSK) isn't the only white-hot dividend stock lurking in the pharmaceuticals space. More »

My 3 favourite FTSE 100 5% yielders

Rupert Hargreaves shares his three favourite FTSE 100 (INDEXFTSE: UKX) income stocks and he thinks they have growth potential. More »

How I’m building a second income with high yielders GSK and Royal Dutch Shell

Edward Sheldon explains how he collects regular dividend cheques from Royal Dutch Shell plc (LON: RDSB) and GlaxoSmithKline plc (LON: GSK). More »

Why the GSK share price should smash the FTSE 100 this year

Roland Head takes a look at FTSE 100 (INDEXFTSE:UKX) climber GlaxoSmithKline plc (LON:GSK) and highlights another turnaround opportunity. More »

Is GSK’s share price the Footsie bargain of 2018?

Does GlaxoSmithKline plc (LON: GSK) offer a potent risk/reward ratio for the long term? More »

Why I’d still buy FTSE 100 giant GlaxoSmithKline but avoid this growth stock

G A Chester sees reasons to shun a small-cap growth stock with an uncertain outlook in favour of GlaxoSmithKline plc (LON:GSK). More »

Why I’d buy this growth stock alongside GlaxoSmithKline

Defensive dividend income from GlaxoSmithKline plc (LON: GSK) could complement this stock’s growth potential.   More »

2 stocks I’d buy and hold for the next 20 years

If you had to decide on 2 shares to buy now but were not allowed to sell them for 20 years, what would you... More »

GlaxoSmithKline’s share price and 5% dividend yield make it my buy of the decade

Harvey Jones says the combination of a cut price valuation and 5% plus yield make GlaxoSmithKline plc (LON: GSK) a rare opportunity for long-term... More »

Why GlaxoSmithKline’s share price could be about to skyrocket

A 5%+ yield, double-digit profit growth, improving balance sheet and dirt-cheap valuation put GlaxoSmithKline plc (LON: GSK) in a fantastic position. More »

GlaxoSmithKline’s share price is rising. Is it time to buy?

GlaxoSmithKline plc's (LON: GSK) share price has bounced 10% in the last few weeks. Is now the time to take a closer look at... More »

Why I believe the GlaxoSmithKline share price is now too cheap to ignore

I believe the GlaxoSmithKline plc (LON: GSK) share price can only go up from here. More »

GlaxoSmithKline plc isn’t the only pharma stock I’d buy today

Royston Wild explains why GlaxoSmithKline plc (LON: GSK) isn't the only pharma star that could make you a fortune. More »

Top shares for April

We asked our analysts to share their top stock picks for the month. More »

Why I’d buy 6% yielder GlaxoSmithKline plc for my ISA after this news

A new deal has lifted the GlaxoSmithKline plc (LON:GSK) share price. Roland Head explains why he'd rate the stock as a buy. More »